Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recruiting × Primary Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 551 Neoplasms 457 Prostatic Neoplasms 291 Lung Neoplasms 220 Colorectal Neoplasms 185 Motor Activity 124 Carcinoma, Non-Small-Cell Lung 104 Uterine Cervical Neoplasms 103 Pancreatic Neoplasms 99 Head and Neck Neoplasms 98 Carcinoma, Hepatocellular 96 Stomach Neoplasms 89 Rectal Neoplasms 89 Brain Neoplasms 89 Colonic Neoplasms 78 Ovarian Neoplasms 75 Esophageal Neoplasms 65 Neoplasm Metastasis 61 Urinary Bladder Neoplasms 60 Multiple Myeloma 58 Melanoma 58 Sarcoma 55 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Lymphoma 54 Hematologic Neoplasms 53 Endometrial Neoplasms 53 Glioma 50 Glioblastoma 50 Leukemia, Myeloid, Acute 47 Anxiety Disorders 46

Interventions

Darbepoetin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting

Primary Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡